Press coverage about Express Scripts (NASDAQ:ESRX) has been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Express Scripts earned a news impact score of 0.17 on Accern’s scale. Accern also gave media coverage about the company an impact score of 45.9296637596179 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the news headlines that may have effected Accern Sentiment Analysis’s rankings:
- Express Scripts Holding Company (ESRX) Optimistic EPS Growth … – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Analyze Stocks Using Technical Indicators – Express Scripts Holding Company (ESRX) – Wall Street Morning (wallstreetmorning.com)
- Express Scripts Holding (ESRX) Sees Large Drop in Short Interest (americanbankingnews.com)
- Turning Focus Towards Fairmount Santrol Holdings Inc. (FMSA) and Express Scripts Holding Company (ESRX … – Market Movers (financialqz.com)
- Express Scripts Holding Company (ESRX) Stock Swings Under EPS Growth Analysis For This Year – Wallstreet Investorplace (wallstreetinvestorplace.com)
A number of analysts have weighed in on the stock. SunTrust Banks set a $82.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a research note on Thursday, December 14th. Jefferies Group reiterated a “buy” rating on shares of Express Scripts in a research note on Thursday, October 26th. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price target for the company in a research note on Monday, October 16th. Royal Bank of Canada set a $68.00 price target on shares of Express Scripts and gave the stock a “hold” rating in a research note on Friday, December 15th. Finally, Mizuho set a $86.00 price target on shares of Express Scripts and gave the stock a “hold” rating in a research note on Wednesday, January 24th. Six equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $78.23.
Shares of Express Scripts (NASDAQ:ESRX) opened at $72.89 on Tuesday. The stock has a market cap of $40,614.61, a P/E ratio of 10.48, a PEG ratio of 0.77 and a beta of 0.93. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts has a 1 year low of $55.80 and a 1 year high of $83.49.
Express Scripts announced that its Board of Directors has authorized a stock repurchase program on Monday, December 18th that allows the company to repurchase 45,000,000 outstanding shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.
In other news, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the sale, the vice president now directly owns 33,715 shares of the company’s stock, valued at $2,730,915. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Christine Houston sold 10,104 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at $6,124,992. The disclosure for this sale can be found here. Insiders sold 17,001 shares of company stock worth $1,249,505 in the last 90 days. 0.68% of the stock is currently owned by company insiders.
WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Express Scripts (ESRX) Share Price” was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://ledgergazette.com/2018/02/13/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-express-scripts-esrx-share-price.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.